Myeloperoxidase–A bridge linking inflammation and oxidative stress with cardiovascular disease

G Ndrepepa - Clinica chimica acta, 2019 - Elsevier
Myeloperoxidase (MPO) is a member of the superfamily of heme peroxidases that is mainly
expressed in neutrophils and monocytes. MPO-derived reactive species play a key role in …

[PDF][PDF] Oxidative stress and cardiovascular disease: new insights

P Pignatelli, D Menichelli, D Pastori… - … Polska (Polish Heart …, 2018 - journals.viamedica.pl
Oxidative stress and cardiovascular disease: new insights Page 1 Address for correspondence:
Prof. Francesco Violi, I Clinica Medica, Viale del Policlinico 155, Roma, 00161, Italy, tel …

Inflammation in peripheral artery disease

G Brevetti, G Giugliano, L Brevetti, WR Hiatt - Circulation, 2010 - Am Heart Assoc
Peripheral artery disease (PAD), which consists of partial or complete obstruction of the
arteries in the lower limbs, is one of the most common manifestations of atherosclerosis …

Tracking the inflammatory response in stroke in vivo by sensing the enzyme myeloperoxidase

MO Breckwoldt, JW Chen… - Proceedings of the …, 2008 - National Acad Sciences
Inflammation can extend ischemic brain injury and adversely affect outcome in experimental
animal models. A key difficulty in translating animal studies to humans is the lack of a …

Myeloperoxidase: a useful biomarker for cardiovascular disease risk stratification?

RK Schindhelm, LP van der Zwan, T Teerlink… - Clinical …, 2009 - academic.oup.com
Background: Inflammation and oxidative stress are associated with atherosclerosis.
Myeloperoxidase (MPO) is linked to both inflammation and oxidative stress by its location in …

Atherothrombosis and oxidative stress: mechanisms and management in elderly

F Violi, L Loffredo, R Carnevale… - Antioxidants & redox …, 2017 - liebertpub.com
Significance: The incidence of cardiovascular events (CVEs) increases with age,
representing the main cause of death in an elderly population. Aging is associated with …

Myeloperoxidase: expressing inflammation and oxidative stress in cardiovascular disease

N Anatoliotakis, S Deftereos, G Bouras… - Current topics in …, 2013 - ingentaconnect.com
Myeloperoxidase (MPO), a heme protein released by leukocytes, is one of the most widely
studied during the last decades molecule that plays a crucial role in inflammation and …

Plasma biomarkers to predict cardiovascular outcome in patients with peripheral artery disease: a systematic review and meta-analysis

B Kremers, L Wübbeke, B Mees… - … , and vascular biology, 2020 - Am Heart Assoc
Objective: Patients with lower extremity peripheral artery disease (PAD) are at increased risk
of major adverse cardiovascular events. Numerous plasma biomarkers have been …

Myeloperoxidase: A versatile mediator of endothelial dysfunction and therapeutic target during cardiovascular disease

SL Maiocchi, J Ku, T Thai, E Chan, MD Rees… - Pharmacology & …, 2021 - Elsevier
Myeloperoxidase (MPO) is a prominent mammalian heme peroxidase and a fundamental
component of the innate immune response against microbial pathogens. In recent times …

Myeloperoxidase as a multifaceted target for cardiovascular protection

CJA Ramachandra, KPMM Ja, J Chua… - Antioxidants & redox …, 2020 - liebertpub.com
Significance: Myeloperoxidase (MPO) is a heme peroxidase that is primarily expressed by
neutrophils. It has the capacity to generate several reactive species, essential for its inherent …